SCHEMBL24344829

SCHEMBL24344829

CC(C)c1ccc2sc(CC(C)c3ccc4nc(CC(C)c5ccc6nccn6c5)sc4c3)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
SCN4A P35499 1/20 0.39
AKR1B1 P15121 3/20 0.37
HDAC6 Q9UBN7 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
NPY1R P25929 1/20 0.32
HTT P42858 1/20 0.32
NPY2R P49146 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MET P08581 2/20 0.32
NQO2 P16083 1/20 0.32
OGA O60502 1/20 0.32
LRRK2 Q5S007 1/20 0.31
ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26364368 0.95 NPC1 (0.42) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL19954923 0.76 NPC1 (0.40) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL19966718 0.74 RAB9A (0.49) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL24420726 0.74 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL19966707 0.74 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL19308856 0.73 NPC1 (0.48) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL26339590 0.72 NPC1 (0.44) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL20098045 0.70 NPC1 (0.45) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL18898373 0.70 HDAC6 (0.37) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1
SCHEMBL20883882 0.69 HDAC6 (0.36) NPC1RAB9ASMN1; SMN2SCN4AAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076975-A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed